The Kite Board

Laurence Debroux

Laurence Debroux is a member of the Board of Directors of Novo Nordisk A/S (Denmark), Exor N.V. ( the Netherlands), Juventus Football Club S.p.A. (Italy) and HEC Paris Business School. She holds the position of Chair of the Audit Committee of the Board of Directors at Novo Nordisk and Exor. She is also a member in remuneration and ESG committees.

Previously, Laurence Debroux held a number of executive positions in multinational companies. From 2015 to 2021 she was Executive Board Member and group Chief Financial Officer of Heineken N.V. From 2010 to 2015 she held the position of Executive Board Member and group Chief Administration and Finance Officer at JCDecaux. From 1996 to 2010 she held a number of positions at Sanofi Aventis (and Sanofi), including those of Chief Srategic Officer and Group Chief Financial Officer.

Her competences include global corporate leadership, strategy, finance, M&A, external innovation partnerships, human capital management, environmental, social and governance (ESG).

Laurence Debroux is a French national, born in July 1969. She holds a Master Degree from HEC Paris, France (1992).

Charles Antoine-Janssen

Charles-Antoine Janssen is an impact investor focused on healthcare access. Charles is a co-founder and Managing Partner of Kois s.a., a global impact investment firm (blended finance structuring and investment management) active in healthcare, education/skilling and living environments. He is the Chief Investment Officer of HealthQuad (India’s largest health tech venture capital fund; a joint venture fund between Kois and Quadria). Charles is an Operating Partner of Quadria (Asia’s largest healthcare to placfund). He is a Partner of Impact Expansion, Kois’ European PE Impact fund. He serves on the board of the following private companies: Medikabazaar, THB, Regency Hospitals, Lilac Insights, Ovum, TC4AI, The Climate School and Potential Project. Charles worked for Merrill Lynch in London from 1996-2000 where he was Vice President of Equities Research, and then Vice President of New Derivatives, Europe. In 2001, Charles joined UCB as Head of Global Business Development. Following the acquisition of Celltech, Charles moved to operations in 2005 as General Manager of Austria, then India. From 2010-2012, he managed International Major Markets Operations. He joined the board of Tubize in 2011, the board of UCB in 2012 and UCB’s Audit Committee in 2015. Charles has founded and served several socially driven non-profit organizations, Toolbox Belgium and Toolbox India, among others. Charles and his Kois colleagues structured and put in place the first humanitarian impact bond and the first refugees impact bond.